CEFADROXIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefadroxil, and what generic alternatives are available?
Cefadroxil is a drug marketed by Aurobindo Pharma, Chartwell Rx, Cspc Ouyi, Hikma, Ivax Sub Teva Pharms, Lupin, Purepac Pharm, Ranbaxy Labs Ltd, Sandoz, Teva, Teva Pharms, Ani Pharms, Apothecon, Aurobindo, Hikma Pharms, Sun Pharm Inds Ltd, and Ranbaxy. and is included in twenty-three NDAs.
The generic ingredient in CEFADROXIL is cefadroxil/cefadroxil hemihydrate. Twenty-two suppliers are listed for this compound. Additional details are available on the cefadroxil/cefadroxil hemihydrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFADROXIL?
- What are the global sales for CEFADROXIL?
- What is Average Wholesale Price for CEFADROXIL?
Summary for CEFADROXIL
| US Patents: | 0 |
| Applicants: | 17 |
| NDAs: | 23 |
| Finished Product Suppliers / Packagers: | 22 |
| Raw Ingredient (Bulk) Api Vendors: | 69 |
| Clinical Trials: | 12 |
| Patent Applications: | 5,810 |
| Drug Prices: | Drug price information for CEFADROXIL |
| DailyMed Link: | CEFADROXIL at DailyMed |
Recent Clinical Trials for CEFADROXIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hasanuddin University | Phase 4 |
| Rothman Institute Orthopaedics | Phase 3 |
| University of Colorado, Denver | Phase 1 |
Pharmacology for CEFADROXIL
| Drug Class | Cephalosporin Antibacterial |
US Patents and Regulatory Information for CEFADROXIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | TABLET;ORAL | 065260-001 | Mar 30, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm Inds Ltd | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | FOR SUSPENSION;ORAL | 065115-001 | Mar 26, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ranbaxy | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | TABLET;ORAL | 065018-001 | Apr 23, 1999 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm Inds Ltd | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | FOR SUSPENSION;ORAL | 065115-002 | Mar 26, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aurobindo Pharma | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | CAPSULE;ORAL | 065352-001 | Jan 25, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Apothecon | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | FOR SUSPENSION;ORAL | 062334-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma Pharms | CEFADROXIL | cefadroxil/cefadroxil hemihydrate | FOR SUSPENSION;ORAL | 091036-001 | Nov 28, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
